Holland Bloorview Kids Rehabilitation Hospital, together with CIBC declared a research study.
This clinical research analysis is based on robotics therapy for cerebral palsy-affected kids. Being Canada’s most prevalent physical disability among children, Cerebral palsy affects one among 300 children.
With $500,000 sponsorship from CIBC and co-directed by Dr. Darcy Fehlings and Dr. Virginia Wright, this two-and-a-half year clinical research study was conducted as a known randomized trial for the first time. It assesses the effect of robotic-based gait training for cerebral palsy affected kids. Based on this research study, Holland Bloorview will formulate methodologies and strategies for clinical application of robotic therapy using the device ‘Pediatric Lokomat Pro’.
CIBC has sponsored the clinical research carried out with Pediatric Lokomat Pro, a high-tech robotic device. THREE TO BE foundation and co-workers has donated this special equipment to Holland Bloorview. The revolutionary gait training device assists a child to walk erectly, while robotics can activate the child's legs similar to normal walking pattern.; The device also includes an incorporated virtual reality screen that enables the kids to select a character to walk along. The motor learning effect is intensified as the walking activity of the patient increases. The virtual reality systems and biofeedback in-built within the device lokomat provides a fun and inspirational environment for the patient, giving both the patient and therapist a direct, real-time feedback.
Robotic therapy presents revolutionizing treatment for children affected with cerebral palsy. This innovative walking therapy is more effective and promising for children with diverse range of walking intentions and abilities.
Supported by organizations such as KRG Children's Charitable Foundation, CIBC, and THREE TO BE, Holland Bloorview will perform an innovative clinical research trial with lokomat.